An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person reported losing 135 pounds in 2.8 years while taking Mounjaro. That’s the simple claim: big weight loss over a multi-year period attributed to this prescription medication. There’s no linked study or official report here — just the headline-style claim about a large personal outcome. Mounjaro is the brand name for tirzepatide. It’s a prescription injection that acts like two natural gut hormones that help control appetite and blood sugar. One of those hormones tells your brain you’re full; the other helps manage insulin and blood sugar. In practice, people tend to eat less and sometimes lose weight while on it. Doctors prescribe it for type 2 diabetes, and some prescribers also use it to help with weight loss. What we don’t have here is a controlled study to examine that specific 135-pound claim. Rigorous clinical trials of tirzepatide have shown substantial average weight loss for many participants, but individual results vary a lot. Trials typically involve groups of people followed by researchers under set conditions, not single anecdotes. A single person losing 135 pounds over nearly three years could reflect a mix of the drug’s effect, lifestyle changes, diet, exercise, starting weight, and other health factors. Personal stories can inspire but don’t prove the same outcome would happen for someone else. Why this matters is straightforward: large weight changes can affect health risks like diabetes, blood pressure, and joint stress. People carrying a lot of excess weight often look for effective options, and newer drugs like tirzepatide have become prominent because they can produce more weight loss than older treatments. If you’re obese or have type 2 diabetes, this kind of medication could be relevant to conversations with your doctor about treatment plans. There are important caveats and risks. Common side effects include nausea, vomiting, diarrhea, and constipation — symptoms that can be severe enough for some people to stop the drug. Long-term safety beyond the timeframe of trials is still being studied. These drugs aren’t appropriate for everyone: they’re prescription-only and not recommended for people with a history of certain thyroid tumors or for pregnant people. Stopping the drug can lead to weight regain if other habits or supports aren’t in place. Regulatory approvals vary by country and by the specific use (diabetes vs. weight loss), so medical supervision is essential. Bottom line: this reported 135-pound loss on Mounjaro is impressive but anecdotal; tirzepatide can produce big weight loss for many people, yet individual results, side effects, and long-term effects vary, so talk with a clinician before drawing conclusions for yourself.
Source: r/Mounjaro